nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Doxorubicin—pancreatic cancer	0.337	0.467	CbGbCtD
L-Carnitine—CES1—Tamoxifen—pancreatic cancer	0.16	0.222	CbGbCtD
L-Carnitine—CES1—Irinotecan—pancreatic cancer	0.123	0.171	CbGbCtD
L-Carnitine—XDH—Doxorubicin—pancreatic cancer	0.058	0.0806	CbGbCtD
L-Carnitine—SLCO1B1—Irinotecan—pancreatic cancer	0.0422	0.0587	CbGbCtD
L-Carnitine—MPO—superior mesenteric artery—pancreatic cancer	0.0345	0.428	CbGeAlD
L-Carnitine—SLC25A29—islet of Langerhans—pancreatic cancer	0.00601	0.0744	CbGeAlD
L-Carnitine—SLC25A20—islet of Langerhans—pancreatic cancer	0.00479	0.0594	CbGeAlD
L-Carnitine—CRAT—islet of Langerhans—pancreatic cancer	0.00465	0.0576	CbGeAlD
L-Carnitine—SLC25A29—pancreas—pancreatic cancer	0.00422	0.0523	CbGeAlD
L-Carnitine—CPT1A—islet of Langerhans—pancreatic cancer	0.00377	0.0467	CbGeAlD
L-Carnitine—SLC25A20—pancreas—pancreatic cancer	0.00337	0.0417	CbGeAlD
L-Carnitine—CRAT—pancreas—pancreatic cancer	0.00327	0.0405	CbGeAlD
L-Carnitine—CES1—gall bladder—pancreatic cancer	0.00324	0.0401	CbGeAlD
L-Carnitine—CPT1A—pancreas—pancreatic cancer	0.00265	0.0328	CbGeAlD
L-Carnitine—CPT1A—digestive system—pancreatic cancer	0.00226	0.028	CbGeAlD
L-Carnitine—XDH—digestive system—pancreatic cancer	0.00167	0.0207	CbGeAlD
L-Carnitine—CES1—digestive system—pancreatic cancer	0.00128	0.0158	CbGeAlD
L-Carnitine—MPO—pancreas—pancreatic cancer	0.00125	0.0154	CbGeAlD
L-Carnitine—SLCO1B1—digestive system—pancreatic cancer	0.0011	0.0136	CbGeAlD
L-Carnitine—MPO—digestive system—pancreatic cancer	0.00107	0.0132	CbGeAlD
L-Carnitine—SLC22A4—digestive system—pancreatic cancer	0.000973	0.012	CbGeAlD
L-Carnitine—SLC22A5—digestive system—pancreatic cancer	0.000644	0.00797	CbGeAlD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000317	0.00502	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—HES1—pancreatic cancer	0.000317	0.00502	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—PLAU—pancreatic cancer	0.000317	0.00501	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000316	0.00501	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PRSS1—pancreatic cancer	0.000312	0.00493	CbGpPWpGaD
L-Carnitine—MPO—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.000305	0.00482	CbGpPWpGaD
L-Carnitine—Pruritus—Tamoxifen—pancreatic cancer	0.000302	0.00222	CcSEcCtD
L-Carnitine—Myalgia—Fluorouracil—pancreatic cancer	0.000301	0.00221	CcSEcCtD
L-Carnitine—Chest pain—Fluorouracil—pancreatic cancer	0.000301	0.00221	CcSEcCtD
L-Carnitine—Infection—Irinotecan—pancreatic cancer	0.0003	0.0022	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000299	0.0022	CcSEcCtD
L-Carnitine—Pruritus—Erlotinib—pancreatic cancer	0.000299	0.0022	CcSEcCtD
L-Carnitine—XDH—Nucleotide metabolism—TYMS—pancreatic cancer	0.000296	0.00468	CbGpPWpGaD
L-Carnitine—Haemoglobin—Docetaxel—pancreatic cancer	0.000295	0.00217	CcSEcCtD
L-Carnitine—Rhinitis—Docetaxel—pancreatic cancer	0.000294	0.00216	CcSEcCtD
L-Carnitine—Haemorrhage—Docetaxel—pancreatic cancer	0.000293	0.00216	CcSEcCtD
L-Carnitine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000292	0.00215	CcSEcCtD
L-Carnitine—Infection—Gemcitabine—pancreatic cancer	0.000292	0.00214	CcSEcCtD
L-Carnitine—Pharyngitis—Docetaxel—pancreatic cancer	0.000291	0.00214	CcSEcCtD
L-Carnitine—Body temperature increased—Sunitinib—pancreatic cancer	0.000289	0.00213	CcSEcCtD
L-Carnitine—Abdominal pain—Sunitinib—pancreatic cancer	0.000289	0.00213	CcSEcCtD
L-Carnitine—Diarrhoea—Erlotinib—pancreatic cancer	0.000289	0.00213	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—EZH2—pancreatic cancer	0.000289	0.00458	CbGpPWpGaD
L-Carnitine—Oedema peripheral—Docetaxel—pancreatic cancer	0.000289	0.00212	CcSEcCtD
L-Carnitine—Anorexia—Irinotecan—pancreatic cancer	0.000287	0.00211	CcSEcCtD
L-Carnitine—Infection—Fluorouracil—pancreatic cancer	0.000287	0.00211	CcSEcCtD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000287	0.00454	CbGpPWpGaD
L-Carnitine—Dizziness—Tamoxifen—pancreatic cancer	0.000283	0.00208	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—HSPA1A—pancreatic cancer	0.000282	0.00447	CbGpPWpGaD
L-Carnitine—Tachycardia—Fluorouracil—pancreatic cancer	0.000282	0.00207	CcSEcCtD
L-Carnitine—Hypotension—Irinotecan—pancreatic cancer	0.000282	0.00207	CcSEcCtD
L-Carnitine—Anorexia—Gemcitabine—pancreatic cancer	0.00028	0.00206	CcSEcCtD
L-Carnitine—Dizziness—Erlotinib—pancreatic cancer	0.00028	0.00205	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—PIK3CB—pancreatic cancer	0.000277	0.00438	CbGpPWpGaD
L-Carnitine—Anorexia—Fluorouracil—pancreatic cancer	0.000275	0.00202	CcSEcCtD
L-Carnitine—Hypotension—Gemcitabine—pancreatic cancer	0.000274	0.00202	CcSEcCtD
L-Carnitine—Eye disorder—Docetaxel—pancreatic cancer	0.000274	0.00201	CcSEcCtD
L-Carnitine—Insomnia—Irinotecan—pancreatic cancer	0.000273	0.002	CcSEcCtD
L-Carnitine—Vomiting—Tamoxifen—pancreatic cancer	0.000272	0.002	CcSEcCtD
L-Carnitine—Paraesthesia—Irinotecan—pancreatic cancer	0.000271	0.00199	CcSEcCtD
L-Carnitine—CROT—Metabolism—ARG2—pancreatic cancer	0.00027	0.00428	CbGpPWpGaD
L-Carnitine—Hypotension—Fluorouracil—pancreatic cancer	0.00027	0.00198	CcSEcCtD
L-Carnitine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00027	0.00198	CcSEcCtD
L-Carnitine—Rash—Tamoxifen—pancreatic cancer	0.000269	0.00198	CcSEcCtD
L-Carnitine—Dermatitis—Tamoxifen—pancreatic cancer	0.000269	0.00198	CcSEcCtD
L-Carnitine—Vomiting—Erlotinib—pancreatic cancer	0.000269	0.00198	CcSEcCtD
L-Carnitine—Dyspnoea—Irinotecan—pancreatic cancer	0.000269	0.00197	CcSEcCtD
L-Carnitine—Headache—Tamoxifen—pancreatic cancer	0.000268	0.00197	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000268	0.00197	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—STAT3—pancreatic cancer	0.000267	0.00423	CbGpPWpGaD
L-Carnitine—Rash—Erlotinib—pancreatic cancer	0.000267	0.00196	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.000266	0.00422	CbGpPWpGaD
L-Carnitine—Dermatitis—Erlotinib—pancreatic cancer	0.000266	0.00196	CcSEcCtD
L-Carnitine—Angiopathy—Docetaxel—pancreatic cancer	0.000266	0.00196	CcSEcCtD
L-Carnitine—Insomnia—Gemcitabine—pancreatic cancer	0.000266	0.00195	CcSEcCtD
L-Carnitine—Dyspepsia—Irinotecan—pancreatic cancer	0.000265	0.00195	CcSEcCtD
L-Carnitine—CRAT—Metabolism—PRSS1—pancreatic cancer	0.000265	0.0042	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PRSS1—pancreatic cancer	0.000265	0.0042	CbGpPWpGaD
L-Carnitine—Headache—Erlotinib—pancreatic cancer	0.000265	0.00195	CcSEcCtD
L-Carnitine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000264	0.00194	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000263	0.00416	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000263	0.00193	CcSEcCtD
L-Carnitine—Asthenia—Sunitinib—pancreatic cancer	0.000263	0.00193	CcSEcCtD
L-Carnitine—Decreased appetite—Irinotecan—pancreatic cancer	0.000262	0.00193	CcSEcCtD
L-Carnitine—Arrhythmia—Docetaxel—pancreatic cancer	0.000262	0.00193	CcSEcCtD
L-Carnitine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000262	0.00192	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000262	0.00414	CbGpPWpGaD
L-Carnitine—Insomnia—Fluorouracil—pancreatic cancer	0.000261	0.00192	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00026	0.00191	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—RB1—pancreatic cancer	0.00026	0.00412	CbGpPWpGaD
L-Carnitine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000259	0.00191	CcSEcCtD
L-Carnitine—Pruritus—Sunitinib—pancreatic cancer	0.000259	0.0019	CcSEcCtD
L-Carnitine—Pain—Irinotecan—pancreatic cancer	0.000258	0.00189	CcSEcCtD
L-Carnitine—Constipation—Irinotecan—pancreatic cancer	0.000258	0.00189	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000258	0.00408	CbGpPWpGaD
L-Carnitine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000257	0.00189	CcSEcCtD
L-Carnitine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000255	0.00188	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000255	0.00403	CbGpPWpGaD
L-Carnitine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000254	0.00187	CcSEcCtD
L-Carnitine—Nausea—Tamoxifen—pancreatic cancer	0.000254	0.00187	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000254	0.00186	CcSEcCtD
L-Carnitine—Gastritis—Epirubicin—pancreatic cancer	0.000253	0.00186	CcSEcCtD
L-Carnitine—Muscular weakness—Epirubicin—pancreatic cancer	0.000252	0.00185	CcSEcCtD
L-Carnitine—Constipation—Gemcitabine—pancreatic cancer	0.000251	0.00185	CcSEcCtD
L-Carnitine—Pain—Gemcitabine—pancreatic cancer	0.000251	0.00185	CcSEcCtD
L-Carnitine—Nausea—Erlotinib—pancreatic cancer	0.000251	0.00185	CcSEcCtD
L-Carnitine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000251	0.00184	CcSEcCtD
L-Carnitine—Diarrhoea—Sunitinib—pancreatic cancer	0.00025	0.00184	CcSEcCtD
L-Carnitine—Dysgeusia—Docetaxel—pancreatic cancer	0.00025	0.00184	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000249	0.00183	CcSEcCtD
L-Carnitine—Influenza—Epirubicin—pancreatic cancer	0.000247	0.00182	CcSEcCtD
L-Carnitine—Back pain—Docetaxel—pancreatic cancer	0.000247	0.00181	CcSEcCtD
L-Carnitine—Pain—Fluorouracil—pancreatic cancer	0.000247	0.00181	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000247	0.00181	CcSEcCtD
L-Carnitine—Muscle spasms—Docetaxel—pancreatic cancer	0.000246	0.0018	CcSEcCtD
L-Carnitine—Dizziness—Sunitinib—pancreatic cancer	0.000242	0.00178	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.00024	0.0038	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—PPARG—pancreatic cancer	0.00024	0.0038	CbGpPWpGaD
L-Carnitine—Abdominal pain—Irinotecan—pancreatic cancer	0.000238	0.00175	CcSEcCtD
L-Carnitine—Body temperature increased—Irinotecan—pancreatic cancer	0.000238	0.00175	CcSEcCtD
L-Carnitine—Bronchitis—Epirubicin—pancreatic cancer	0.000238	0.00175	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000238	0.00376	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—TYMP—pancreatic cancer	0.000236	0.00374	CbGpPWpGaD
L-Carnitine—Anaemia—Docetaxel—pancreatic cancer	0.000236	0.00173	CcSEcCtD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	0.000235	0.00372	CbGpPWpGaD
L-Carnitine—Gastritis—Doxorubicin—pancreatic cancer	0.000234	0.00172	CcSEcCtD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	0.000234	0.0037	CbGpPWpGaD
L-Carnitine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000233	0.00171	CcSEcCtD
L-Carnitine—Vomiting—Sunitinib—pancreatic cancer	0.000233	0.00171	CcSEcCtD
L-Carnitine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000232	0.00171	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—TNF—pancreatic cancer	0.000231	0.00366	CbGpPWpGaD
L-Carnitine—Rash—Sunitinib—pancreatic cancer	0.000231	0.0017	CcSEcCtD
L-Carnitine—Dermatitis—Sunitinib—pancreatic cancer	0.000231	0.00169	CcSEcCtD
L-Carnitine—CRAT—Metabolism—ARG2—pancreatic cancer	0.00023	0.00364	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—ARG2—pancreatic cancer	0.00023	0.00364	CbGpPWpGaD
L-Carnitine—Headache—Sunitinib—pancreatic cancer	0.000229	0.00168	CcSEcCtD
L-Carnitine—Influenza—Doxorubicin—pancreatic cancer	0.000229	0.00168	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000229	0.00362	CbGpPWpGaD
L-Carnitine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000228	0.00168	CcSEcCtD
L-Carnitine—Palpitations—Docetaxel—pancreatic cancer	0.000226	0.00166	CcSEcCtD
L-Carnitine—Weight increased—Epirubicin—pancreatic cancer	0.000225	0.00165	CcSEcCtD
L-Carnitine—Weight decreased—Epirubicin—pancreatic cancer	0.000224	0.00164	CcSEcCtD
L-Carnitine—Cough—Docetaxel—pancreatic cancer	0.000223	0.00164	CcSEcCtD
L-Carnitine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000222	0.00163	CcSEcCtD
L-Carnitine—Convulsion—Docetaxel—pancreatic cancer	0.000221	0.00163	CcSEcCtD
L-Carnitine—Hypertension—Docetaxel—pancreatic cancer	0.00022	0.00162	CcSEcCtD
L-Carnitine—Bronchitis—Doxorubicin—pancreatic cancer	0.00022	0.00162	CcSEcCtD
L-Carnitine—Myalgia—Docetaxel—pancreatic cancer	0.000217	0.0016	CcSEcCtD
L-Carnitine—Chest pain—Docetaxel—pancreatic cancer	0.000217	0.0016	CcSEcCtD
L-Carnitine—Nausea—Sunitinib—pancreatic cancer	0.000217	0.0016	CcSEcCtD
L-Carnitine—Renal failure—Epirubicin—pancreatic cancer	0.000217	0.00159	CcSEcCtD
L-Carnitine—Asthenia—Irinotecan—pancreatic cancer	0.000216	0.00159	CcSEcCtD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000215	0.0034	CbGpPWpGaD
L-Carnitine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000214	0.00157	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000214	0.00338	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000213	0.00156	CcSEcCtD
L-Carnitine—Asthenia—Gemcitabine—pancreatic cancer	0.000211	0.00155	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—PIK3CA—pancreatic cancer	0.000211	0.00333	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TYMS—pancreatic cancer	0.000209	0.00331	CbGpPWpGaD
L-Carnitine—Weight increased—Doxorubicin—pancreatic cancer	0.000208	0.00153	CcSEcCtD
L-Carnitine—Pruritus—Gemcitabine—pancreatic cancer	0.000208	0.00153	CcSEcCtD
L-Carnitine—Infection—Docetaxel—pancreatic cancer	0.000207	0.00152	CcSEcCtD
L-Carnitine—Weight decreased—Doxorubicin—pancreatic cancer	0.000207	0.00152	CcSEcCtD
L-Carnitine—Sinusitis—Epirubicin—pancreatic cancer	0.000207	0.00152	CcSEcCtD
L-Carnitine—Diarrhoea—Irinotecan—pancreatic cancer	0.000206	0.00152	CcSEcCtD
L-Carnitine—Pruritus—Fluorouracil—pancreatic cancer	0.000204	0.0015	CcSEcCtD
L-Carnitine—Tachycardia—Docetaxel—pancreatic cancer	0.000203	0.00149	CcSEcCtD
L-Carnitine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000201	0.00148	CcSEcCtD
L-Carnitine—CRAT—Metabolism—TYMP—pancreatic cancer	0.000201	0.00318	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—TYMP—pancreatic cancer	0.000201	0.00318	CbGpPWpGaD
L-Carnitine—Renal failure—Doxorubicin—pancreatic cancer	0.0002	0.00147	CcSEcCtD
L-Carnitine—Dizziness—Irinotecan—pancreatic cancer	0.000199	0.00146	CcSEcCtD
L-Carnitine—Haemoglobin—Epirubicin—pancreatic cancer	0.000199	0.00146	CcSEcCtD
L-Carnitine—Anorexia—Docetaxel—pancreatic cancer	0.000199	0.00146	CcSEcCtD
L-Carnitine—Rhinitis—Epirubicin—pancreatic cancer	0.000198	0.00146	CcSEcCtD
L-Carnitine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000198	0.00146	CcSEcCtD
L-Carnitine—Haemorrhage—Epirubicin—pancreatic cancer	0.000198	0.00145	CcSEcCtD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000198	0.00313	CbGpPWpGaD
L-Carnitine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000198	0.00145	CcSEcCtD
L-Carnitine—Pharyngitis—Epirubicin—pancreatic cancer	0.000196	0.00144	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000195	0.00309	CbGpPWpGaD
L-Carnitine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000195	0.00143	CcSEcCtD
L-Carnitine—Hypotension—Docetaxel—pancreatic cancer	0.000195	0.00143	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000194	0.00307	CbGpPWpGaD
L-Carnitine—Vomiting—Irinotecan—pancreatic cancer	0.000192	0.00141	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000192	0.00303	CbGpPWpGaD
L-Carnitine—Sinusitis—Doxorubicin—pancreatic cancer	0.000191	0.00141	CcSEcCtD
L-Carnitine—Dizziness—Fluorouracil—pancreatic cancer	0.000191	0.0014	CcSEcCtD
L-Carnitine—CROT—Metabolism—GLP1R—pancreatic cancer	0.00019	0.00301	CbGpPWpGaD
L-Carnitine—Rash—Irinotecan—pancreatic cancer	0.00019	0.0014	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CDKN2A—pancreatic cancer	0.00019	0.00301	CbGpPWpGaD
L-Carnitine—Dermatitis—Irinotecan—pancreatic cancer	0.00019	0.0014	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00019	0.0014	CcSEcCtD
L-Carnitine—Headache—Irinotecan—pancreatic cancer	0.000189	0.00139	CcSEcCtD
L-Carnitine—Insomnia—Docetaxel—pancreatic cancer	0.000189	0.00139	CcSEcCtD
L-Carnitine—CROT—Metabolism—DPYD—pancreatic cancer	0.000187	0.00297	CbGpPWpGaD
L-Carnitine—Paraesthesia—Docetaxel—pancreatic cancer	0.000187	0.00138	CcSEcCtD
L-Carnitine—Vomiting—Gemcitabine—pancreatic cancer	0.000187	0.00137	CcSEcCtD
L-Carnitine—Dyspnoea—Docetaxel—pancreatic cancer	0.000186	0.00137	CcSEcCtD
L-Carnitine—Rash—Gemcitabine—pancreatic cancer	0.000185	0.00136	CcSEcCtD
L-Carnitine—Dermatitis—Gemcitabine—pancreatic cancer	0.000185	0.00136	CcSEcCtD
L-Carnitine—Eye disorder—Epirubicin—pancreatic cancer	0.000185	0.00136	CcSEcCtD
L-Carnitine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000184	0.00135	CcSEcCtD
L-Carnitine—Headache—Gemcitabine—pancreatic cancer	0.000184	0.00135	CcSEcCtD
L-Carnitine—Vomiting—Fluorouracil—pancreatic cancer	0.000184	0.00135	CcSEcCtD
L-Carnitine—Rhinitis—Doxorubicin—pancreatic cancer	0.000184	0.00135	CcSEcCtD
L-Carnitine—Dyspepsia—Docetaxel—pancreatic cancer	0.000183	0.00135	CcSEcCtD
L-Carnitine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000183	0.00135	CcSEcCtD
L-Carnitine—Rash—Fluorouracil—pancreatic cancer	0.000182	0.00134	CcSEcCtD
L-Carnitine—Dermatitis—Fluorouracil—pancreatic cancer	0.000182	0.00134	CcSEcCtD
L-Carnitine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000182	0.00134	CcSEcCtD
L-Carnitine—Decreased appetite—Docetaxel—pancreatic cancer	0.000181	0.00133	CcSEcCtD
L-Carnitine—Headache—Fluorouracil—pancreatic cancer	0.000181	0.00133	CcSEcCtD
L-Carnitine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00018	0.00133	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00018	0.00132	CcSEcCtD
L-Carnitine—Angiopathy—Epirubicin—pancreatic cancer	0.00018	0.00132	CcSEcCtD
L-Carnitine—Nausea—Irinotecan—pancreatic cancer	0.000179	0.00132	CcSEcCtD
L-Carnitine—MPO—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.000179	0.00283	CbGpPWpGaD
L-Carnitine—Constipation—Docetaxel—pancreatic cancer	0.000178	0.00131	CcSEcCtD
L-Carnitine—Pain—Docetaxel—pancreatic cancer	0.000178	0.00131	CcSEcCtD
L-Carnitine—CROT—Metabolism—SLC2A2—pancreatic cancer	0.000178	0.00281	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—PTGS2—pancreatic cancer	0.000178	0.00281	CbGpPWpGaD
L-Carnitine—Arrhythmia—Epirubicin—pancreatic cancer	0.000177	0.0013	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000176	0.00279	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000175	0.00277	CbGpPWpGaD
L-Carnitine—Nausea—Gemcitabine—pancreatic cancer	0.000174	0.00128	CcSEcCtD
L-Carnitine—Nausea—Fluorouracil—pancreatic cancer	0.000172	0.00126	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000171	0.00271	CbGpPWpGaD
L-Carnitine—Eye disorder—Doxorubicin—pancreatic cancer	0.000171	0.00126	CcSEcCtD
L-Carnitine—CPT2—Metabolism—PRSS1—pancreatic cancer	0.000171	0.0027	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00017	0.00125	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.00017	0.00269	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—PIK3CA—pancreatic cancer	0.000169	0.00267	CbGpPWpGaD
L-Carnitine—Dysgeusia—Epirubicin—pancreatic cancer	0.000169	0.00124	CcSEcCtD
L-Carnitine—Back pain—Epirubicin—pancreatic cancer	0.000167	0.00122	CcSEcCtD
L-Carnitine—Angiopathy—Doxorubicin—pancreatic cancer	0.000166	0.00122	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000166	0.00262	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000166	0.00262	CbGpPWpGaD
L-Carnitine—Muscle spasms—Epirubicin—pancreatic cancer	0.000166	0.00122	CcSEcCtD
L-Carnitine—Abdominal pain—Docetaxel—pancreatic cancer	0.000165	0.00121	CcSEcCtD
L-Carnitine—Body temperature increased—Docetaxel—pancreatic cancer	0.000165	0.00121	CcSEcCtD
L-Carnitine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000164	0.0012	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—TP53—pancreatic cancer	0.000163	0.00258	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000163	0.00258	CbGpPWpGaD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	0.000162	0.00256	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GLP1R—pancreatic cancer	0.000162	0.00256	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GLP1R—pancreatic cancer	0.000162	0.00256	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—CCND1—pancreatic cancer	0.000161	0.00254	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—DPYD—pancreatic cancer	0.000159	0.00252	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—DPYD—pancreatic cancer	0.000159	0.00252	CbGpPWpGaD
L-Carnitine—Anaemia—Epirubicin—pancreatic cancer	0.000159	0.00117	CcSEcCtD
L-Carnitine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000156	0.00115	CcSEcCtD
L-Carnitine—CES1—E2F transcription factor network—MYC—pancreatic cancer	0.000155	0.00245	CbGpPWpGaD
L-Carnitine—Vertigo—Epirubicin—pancreatic cancer	0.000155	0.00114	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000155	0.00245	CbGpPWpGaD
L-Carnitine—Back pain—Doxorubicin—pancreatic cancer	0.000154	0.00113	CcSEcCtD
L-Carnitine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000154	0.00113	CcSEcCtD
L-Carnitine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000153	0.00113	CcSEcCtD
L-Carnitine—Palpitations—Epirubicin—pancreatic cancer	0.000152	0.00112	CcSEcCtD
L-Carnitine—CRAT—Metabolism—SLC2A2—pancreatic cancer	0.000151	0.00239	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SLC2A2—pancreatic cancer	0.000151	0.00239	CbGpPWpGaD
L-Carnitine—Cough—Epirubicin—pancreatic cancer	0.00015	0.0011	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.00015	0.00237	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.00015	0.00237	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.00015	0.00237	CbGpPWpGaD
L-Carnitine—Asthenia—Docetaxel—pancreatic cancer	0.00015	0.0011	CcSEcCtD
L-Carnitine—Convulsion—Epirubicin—pancreatic cancer	0.000149	0.0011	CcSEcCtD
L-Carnitine—Hypertension—Epirubicin—pancreatic cancer	0.000149	0.00109	CcSEcCtD
L-Carnitine—CPT1A—Circadian rythm related genes—PPARG—pancreatic cancer	0.000148	0.00235	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—ARG2—pancreatic cancer	0.000148	0.00234	CbGpPWpGaD
L-Carnitine—Pruritus—Docetaxel—pancreatic cancer	0.000147	0.00108	CcSEcCtD
L-Carnitine—Anaemia—Doxorubicin—pancreatic cancer	0.000147	0.00108	CcSEcCtD
L-Carnitine—Myalgia—Epirubicin—pancreatic cancer	0.000147	0.00108	CcSEcCtD
L-Carnitine—Chest pain—Epirubicin—pancreatic cancer	0.000147	0.00108	CcSEcCtD
L-Carnitine—Anxiety—Epirubicin—pancreatic cancer	0.000146	0.00107	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—TNF—pancreatic cancer	0.000145	0.0023	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000144	0.00229	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000144	0.00229	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000144	0.00228	CbGpPWpGaD
L-Carnitine—Vertigo—Doxorubicin—pancreatic cancer	0.000143	0.00105	CcSEcCtD
L-Carnitine—Diarrhoea—Docetaxel—pancreatic cancer	0.000143	0.00105	CcSEcCtD
L-Carnitine—Palpitations—Doxorubicin—pancreatic cancer	0.000141	0.00103	CcSEcCtD
L-Carnitine—Infection—Epirubicin—pancreatic cancer	0.00014	0.00103	CcSEcCtD
L-Carnitine—Cough—Doxorubicin—pancreatic cancer	0.000139	0.00102	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000139	0.00219	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—NRAS—pancreatic cancer	0.000138	0.00219	CbGpPWpGaD
L-Carnitine—Convulsion—Doxorubicin—pancreatic cancer	0.000138	0.00101	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—AKT1—pancreatic cancer	0.000138	0.00218	CbGpPWpGaD
L-Carnitine—Dizziness—Docetaxel—pancreatic cancer	0.000138	0.00101	CcSEcCtD
L-Carnitine—CROT—Metabolism—CD44—pancreatic cancer	0.000138	0.00218	CbGpPWpGaD
L-Carnitine—Hypertension—Doxorubicin—pancreatic cancer	0.000138	0.00101	CcSEcCtD
L-Carnitine—Tachycardia—Epirubicin—pancreatic cancer	0.000137	0.00101	CcSEcCtD
L-Carnitine—Chest pain—Doxorubicin—pancreatic cancer	0.000136	0.000997	CcSEcCtD
L-Carnitine—Myalgia—Doxorubicin—pancreatic cancer	0.000136	0.000997	CcSEcCtD
L-Carnitine—Anxiety—Doxorubicin—pancreatic cancer	0.000135	0.000993	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000135	0.00213	CbGpPWpGaD
L-Carnitine—Anorexia—Epirubicin—pancreatic cancer	0.000134	0.000985	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000134	0.00211	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000133	0.00211	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000133	0.0021	CbGpPWpGaD
L-Carnitine—Vomiting—Docetaxel—pancreatic cancer	0.000133	0.000974	CcSEcCtD
L-Carnitine—CROT—Metabolism—GCG—pancreatic cancer	0.000132	0.00209	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000132	0.00208	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000132	0.00208	CbGpPWpGaD
L-Carnitine—Rash—Docetaxel—pancreatic cancer	0.000131	0.000966	CcSEcCtD
L-Carnitine—Hypotension—Epirubicin—pancreatic cancer	0.000131	0.000965	CcSEcCtD
L-Carnitine—Dermatitis—Docetaxel—pancreatic cancer	0.000131	0.000965	CcSEcCtD
L-Carnitine—Headache—Docetaxel—pancreatic cancer	0.000131	0.000959	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00013	0.00206	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—TYMP—pancreatic cancer	0.000129	0.00205	CbGpPWpGaD
L-Carnitine—Infection—Doxorubicin—pancreatic cancer	0.000129	0.000949	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—MYC—pancreatic cancer	0.000129	0.00204	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—pancreatic cancer	0.000128	0.00203	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000128	0.000941	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000128	0.00202	CbGpPWpGaD
L-Carnitine—Insomnia—Epirubicin—pancreatic cancer	0.000127	0.000934	CcSEcCtD
L-Carnitine—Tachycardia—Doxorubicin—pancreatic cancer	0.000127	0.000933	CcSEcCtD
L-Carnitine—Paraesthesia—Epirubicin—pancreatic cancer	0.000126	0.000927	CcSEcCtD
L-Carnitine—Dyspnoea—Epirubicin—pancreatic cancer	0.000125	0.000921	CcSEcCtD
L-Carnitine—CROT—Metabolism—STK11—pancreatic cancer	0.000124	0.00196	CbGpPWpGaD
L-Carnitine—Anorexia—Doxorubicin—pancreatic cancer	0.000124	0.000911	CcSEcCtD
L-Carnitine—Nausea—Docetaxel—pancreatic cancer	0.000124	0.00091	CcSEcCtD
L-Carnitine—Dyspepsia—Epirubicin—pancreatic cancer	0.000124	0.000909	CcSEcCtD
L-Carnitine—Decreased appetite—Epirubicin—pancreatic cancer	0.000122	0.000898	CcSEcCtD
L-Carnitine—Hypotension—Doxorubicin—pancreatic cancer	0.000122	0.000893	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000121	0.000892	CcSEcCtD
L-Carnitine—Constipation—Epirubicin—pancreatic cancer	0.00012	0.000883	CcSEcCtD
L-Carnitine—Pain—Epirubicin—pancreatic cancer	0.00012	0.000883	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—KRAS—pancreatic cancer	0.000119	0.00188	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000119	0.000871	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—PRSS1—pancreatic cancer	0.000118	0.00187	CbGpPWpGaD
L-Carnitine—Insomnia—Doxorubicin—pancreatic cancer	0.000118	0.000864	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—CD44—pancreatic cancer	0.000117	0.00185	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CD44—pancreatic cancer	0.000117	0.00185	CbGpPWpGaD
L-Carnitine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000117	0.000858	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000117	0.00184	CbGpPWpGaD
L-Carnitine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000116	0.000852	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—TNF—pancreatic cancer	0.000116	0.00183	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000115	0.000845	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000115	0.00181	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000115	0.00181	CbGpPWpGaD
L-Carnitine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000115	0.000841	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000114	0.0018	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000114	0.0018	CbGpPWpGaD
L-Carnitine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000113	0.000831	CcSEcCtD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000113	0.00178	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000112	0.000825	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—GCG—pancreatic cancer	0.000112	0.00178	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GCG—pancreatic cancer	0.000112	0.00178	CbGpPWpGaD
L-Carnitine—Pain—Doxorubicin—pancreatic cancer	0.000111	0.000817	CcSEcCtD
L-Carnitine—Constipation—Doxorubicin—pancreatic cancer	0.000111	0.000817	CcSEcCtD
L-Carnitine—Body temperature increased—Epirubicin—pancreatic cancer	0.000111	0.000817	CcSEcCtD
L-Carnitine—Abdominal pain—Epirubicin—pancreatic cancer	0.000111	0.000817	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000107	0.00169	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—TYMS—pancreatic cancer	0.000107	0.00169	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000106	0.000781	CcSEcCtD
L-Carnitine—CRAT—Metabolism—STK11—pancreatic cancer	0.000106	0.00167	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—STK11—pancreatic cancer	0.000106	0.00167	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GLP1R—pancreatic cancer	0.000104	0.00165	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000104	0.000761	CcSEcCtD
L-Carnitine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000103	0.000755	CcSEcCtD
L-Carnitine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000103	0.000755	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—ARG2—pancreatic cancer	0.000103	0.00162	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—DPYD—pancreatic cancer	0.000103	0.00162	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—PTEN—pancreatic cancer	0.000102	0.00161	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—pancreatic cancer	0.000101	0.0016	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—TNF—pancreatic cancer	0.000101	0.0016	CbGpPWpGaD
L-Carnitine—Asthenia—Epirubicin—pancreatic cancer	0.000101	0.000741	CcSEcCtD
L-Carnitine—Pruritus—Epirubicin—pancreatic cancer	9.95e-05	0.000731	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.91e-05	0.00157	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.91e-05	0.00157	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	9.89e-05	0.00157	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SLC2A2—pancreatic cancer	9.74e-05	0.00154	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	9.74e-05	0.00154	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—TNF—pancreatic cancer	9.65e-05	0.00153	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.64e-05	0.00153	CbGpPWpGaD
L-Carnitine—Diarrhoea—Epirubicin—pancreatic cancer	9.62e-05	0.000707	CcSEcCtD
L-Carnitine—Hypersensitivity—Doxorubicin—pancreatic cancer	9.58e-05	0.000704	CcSEcCtD
L-Carnitine—Asthenia—Doxorubicin—pancreatic cancer	9.33e-05	0.000686	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.31e-05	0.00147	CbGpPWpGaD
L-Carnitine—Dizziness—Epirubicin—pancreatic cancer	9.3e-05	0.000683	CcSEcCtD
L-Carnitine—Pruritus—Doxorubicin—pancreatic cancer	9.2e-05	0.000676	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—TYMS—pancreatic cancer	9.08e-05	0.00144	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—TYMS—pancreatic cancer	9.08e-05	0.00144	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TYMP—pancreatic cancer	8.97e-05	0.00142	CbGpPWpGaD
L-Carnitine—Vomiting—Epirubicin—pancreatic cancer	8.94e-05	0.000657	CcSEcCtD
L-Carnitine—Diarrhoea—Doxorubicin—pancreatic cancer	8.9e-05	0.000654	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—TGFB1—pancreatic cancer	8.88e-05	0.00141	CbGpPWpGaD
L-Carnitine—Rash—Epirubicin—pancreatic cancer	8.86e-05	0.000651	CcSEcCtD
L-Carnitine—Dermatitis—Epirubicin—pancreatic cancer	8.86e-05	0.000651	CcSEcCtD
L-Carnitine—Headache—Epirubicin—pancreatic cancer	8.81e-05	0.000647	CcSEcCtD
L-Carnitine—CROT—Metabolism—APOE—pancreatic cancer	8.68e-05	0.00137	CbGpPWpGaD
L-Carnitine—Dizziness—Doxorubicin—pancreatic cancer	8.6e-05	0.000632	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.48e-05	0.00134	CbGpPWpGaD
L-Carnitine—Nausea—Epirubicin—pancreatic cancer	8.35e-05	0.000614	CcSEcCtD
L-Carnitine—Vomiting—Doxorubicin—pancreatic cancer	8.27e-05	0.000608	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.22e-05	0.0013	CbGpPWpGaD
L-Carnitine—Rash—Doxorubicin—pancreatic cancer	8.2e-05	0.000603	CcSEcCtD
L-Carnitine—Dermatitis—Doxorubicin—pancreatic cancer	8.19e-05	0.000602	CcSEcCtD
L-Carnitine—Headache—Doxorubicin—pancreatic cancer	8.15e-05	0.000599	CcSEcCtD
L-Carnitine—XDH—Metabolism—PRSS1—pancreatic cancer	7.84e-05	0.00124	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CG—pancreatic cancer	7.84e-05	0.00124	CbGpPWpGaD
L-Carnitine—Nausea—Doxorubicin—pancreatic cancer	7.73e-05	0.000568	CcSEcCtD
L-Carnitine—CROT—Metabolism—PPARG—pancreatic cancer	7.56e-05	0.0012	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CD44—pancreatic cancer	7.55e-05	0.00119	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.41e-05	0.00117	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.39e-05	0.00117	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—APOE—pancreatic cancer	7.38e-05	0.00117	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—APOE—pancreatic cancer	7.38e-05	0.00117	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.32e-05	0.00116	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.32e-05	0.00116	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GCG—pancreatic cancer	7.23e-05	0.00114	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GLP1R—pancreatic cancer	7.23e-05	0.00114	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—DPYD—pancreatic cancer	7.12e-05	0.00113	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.99e-05	0.00111	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.99e-05	0.00111	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—pancreatic cancer	6.94e-05	0.0011	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CD—pancreatic cancer	6.89e-05	0.00109	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—STK11—pancreatic cancer	6.8e-05	0.00108	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—ARG2—pancreatic cancer	6.8e-05	0.00108	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC2A2—pancreatic cancer	6.75e-05	0.00107	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.68e-05	0.00106	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CG—pancreatic cancer	6.66e-05	0.00105	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CG—pancreatic cancer	6.66e-05	0.00105	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.62e-05	0.00105	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.45e-05	0.00102	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PPARG—pancreatic cancer	6.43e-05	0.00102	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PPARG—pancreatic cancer	6.43e-05	0.00102	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.38e-05	0.00101	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CB—pancreatic cancer	6.01e-05	0.00095	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTGS2—pancreatic cancer	5.95e-05	0.000942	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TYMP—pancreatic cancer	5.94e-05	0.000941	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.88e-05	0.00093	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CD—pancreatic cancer	5.86e-05	0.000927	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CD—pancreatic cancer	5.86e-05	0.000927	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—TYMS—pancreatic cancer	5.85e-05	0.000926	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CD44—pancreatic cancer	5.23e-05	0.000828	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—pancreatic cancer	5.19e-05	0.000821	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.12e-05	0.00081	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CB—pancreatic cancer	5.11e-05	0.000808	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CB—pancreatic cancer	5.11e-05	0.000808	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.07e-05	0.000803	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—pancreatic cancer	5.06e-05	0.000801	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—pancreatic cancer	5.06e-05	0.000801	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.03e-05	0.000796	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GCG—pancreatic cancer	5.01e-05	0.000794	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GLP1R—pancreatic cancer	4.79e-05	0.000758	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APOE—pancreatic cancer	4.76e-05	0.000753	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—STK11—pancreatic cancer	4.71e-05	0.000746	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—DPYD—pancreatic cancer	4.71e-05	0.000746	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.5e-05	0.000713	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC2A2—pancreatic cancer	4.47e-05	0.000708	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.43e-05	0.0007	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—pancreatic cancer	4.41e-05	0.000698	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—pancreatic cancer	4.41e-05	0.000698	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CG—pancreatic cancer	4.29e-05	0.00068	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PPARG—pancreatic cancer	4.14e-05	0.000656	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PRSS1—pancreatic cancer	4.13e-05	0.000653	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TYMS—pancreatic cancer	4.06e-05	0.000642	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CD—pancreatic cancer	3.77e-05	0.000597	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—pancreatic cancer	3.66e-05	0.000579	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—ARG2—pancreatic cancer	3.58e-05	0.000567	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CD44—pancreatic cancer	3.46e-05	0.000548	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GCG—pancreatic cancer	3.32e-05	0.000526	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APOE—pancreatic cancer	3.3e-05	0.000522	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CB—pancreatic cancer	3.29e-05	0.000521	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—pancreatic cancer	3.26e-05	0.000516	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TYMP—pancreatic cancer	3.13e-05	0.000495	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—STK11—pancreatic cancer	3.12e-05	0.000494	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.12e-05	0.000494	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—pancreatic cancer	3.11e-05	0.000493	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—pancreatic cancer	3.11e-05	0.000493	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—pancreatic cancer	2.99e-05	0.000473	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CG—pancreatic cancer	2.98e-05	0.000471	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PPARG—pancreatic cancer	2.87e-05	0.000455	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—pancreatic cancer	2.84e-05	0.00045	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TYMS—pancreatic cancer	2.69e-05	0.000425	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CD—pancreatic cancer	2.62e-05	0.000414	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.58e-05	0.000409	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—pancreatic cancer	2.54e-05	0.000402	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—pancreatic cancer	2.54e-05	0.000402	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	2.52e-05	0.000399	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—DPYD—pancreatic cancer	2.48e-05	0.000393	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	2.35e-05	0.000373	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.33e-05	0.000369	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CB—pancreatic cancer	2.28e-05	0.000361	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—pancreatic cancer	2.26e-05	0.000358	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.25e-05	0.000356	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APOE—pancreatic cancer	2.18e-05	0.000346	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.05e-05	0.000324	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—pancreatic cancer	2.01e-05	0.000317	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CG—pancreatic cancer	1.97e-05	0.000312	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—pancreatic cancer	1.97e-05	0.000312	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PPARG—pancreatic cancer	1.9e-05	0.000301	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CD44—pancreatic cancer	1.82e-05	0.000289	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.79e-05	0.000283	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.77e-05	0.00028	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GCG—pancreatic cancer	1.75e-05	0.000277	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CD—pancreatic cancer	1.73e-05	0.000274	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—STK11—pancreatic cancer	1.64e-05	0.00026	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—pancreatic cancer	1.64e-05	0.000259	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.54e-05	0.000244	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CB—pancreatic cancer	1.51e-05	0.000239	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—pancreatic cancer	1.5e-05	0.000237	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TYMS—pancreatic cancer	1.41e-05	0.000224	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—pancreatic cancer	1.39e-05	0.00022	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—pancreatic cancer	1.31e-05	0.000207	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APOE—pancreatic cancer	1.15e-05	0.000182	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—pancreatic cancer	1.14e-05	0.00018	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.09e-05	0.000172	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	1.04e-05	0.000164	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PPARG—pancreatic cancer	1e-05	0.000159	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—pancreatic cancer	9.21e-06	0.000146	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	9.12e-06	0.000144	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	7.95e-06	0.000126	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	7.88e-06	0.000125	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—pancreatic cancer	7.52e-06	0.000119	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—pancreatic cancer	6.87e-06	0.000109	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	4.85e-06	7.67e-05	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—pancreatic cancer	3.96e-06	6.27e-05	CbGpPWpGaD
